Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Barbour

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2014
Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomyKiarash Khosrotehrani, Augustinus P T van der Ploeg, Victor Siskind, et al.
Annals of Surgical Oncology|November 20, 2015
Australian Multicenter Study of Isolated Limb Infusion for MelanomaHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
BMC Cancer|January 29, 2024
iCare - a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trialPatricia M Livingston, Natalie Winter, Anna Ugalde, et al.
Australian Family Physician|August 11, 2016
Sentinel node biopsy in patients with intermediate and thick melanomas – A balanced viewRobyn Saw, Christopher Allan, Andrew Barbour, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Cancer|October 18, 2025
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survivalKemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2014
Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomyKiarash Khosrotehrani, Augustinus P T van der Ploeg, Victor Siskind, et al.
Annals of Surgical Oncology|November 20, 2015
Australian Multicenter Study of Isolated Limb Infusion for MelanomaHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
BMC Cancer|January 29, 2024
iCare - a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trialPatricia M Livingston, Natalie Winter, Anna Ugalde, et al.
Australian Family Physician|August 11, 2016
Sentinel node biopsy in patients with intermediate and thick melanomas – A balanced viewRobyn Saw, Christopher Allan, Andrew Barbour, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Cancer|October 18, 2025
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survivalKemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, et al.
Pageof 6